157 related articles for article (PubMed ID: 9865723)
1. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
Gorski DH; Mauceri HJ; Salloum RM; Gately S; Hellman S; Beckett MA; Sukhatme VP; Soff GA; Kufe DW; Weichselbaum RR
Cancer Res; 1998 Dec; 58(24):5686-9. PubMed ID: 9865723
[TBL] [Abstract][Full Text] [Related]
2. Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.
Gorski DH; Mauceri HJ; Salloum RM; Halpern A; Seetharam S; Weichselbaum RR
Cancer Res; 2003 Jan; 63(2):308-11. PubMed ID: 12543780
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of angiostatin and ionizing radiation in antitumour therapy.
Mauceri HJ; Hanna NN; Beckett MA; Gorski DH; Staba MJ; Stellato KA; Bigelow K; Heimann R; Gately S; Dhanabal M; Soff GA; Sukhatme VP; Kufe DW; Weichselbaum RR
Nature; 1998 Jul; 394(6690):287-91. PubMed ID: 9685160
[TBL] [Abstract][Full Text] [Related]
4. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
7. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
[TBL] [Abstract][Full Text] [Related]
8. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
9. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
Salloum RM; Jaskowiak NT; Mauceri HJ; Seetharam S; Beckett MA; Koons AM; Hari DM; Gupta VK; Reimer C; Kalluri R; Posner MC; Hellman S; Kufe DW; Weichselbaum RR
Cancer Res; 2000 Dec; 60(24):6958-63. PubMed ID: 11156396
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.
Ambs S; Dennis S; Fairman J; Wright M; Papkoff J
Cancer Res; 1999 Nov; 59(22):5773-7. PubMed ID: 10582698
[TBL] [Abstract][Full Text] [Related]
11. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.
Drixler TA; Borel Rinkes IH; Ritchie ED; van Vroonhoven TJ; Gebbink MF; Voest EE
Cancer Res; 2000 Mar; 60(6):1761-5. PubMed ID: 10749151
[TBL] [Abstract][Full Text] [Related]
12. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
13. [Study on the antitumor effect of angiostatin on LA795 adenocarcinoma cells].
Zheng F; Tong W; Wen J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):34-6. PubMed ID: 11778179
[TBL] [Abstract][Full Text] [Related]
14. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo.
Lannutti BJ; Gately ST; Quevedo ME; Soff GA; Paller AS
Cancer Res; 1997 Dec; 57(23):5277-80. PubMed ID: 9393749
[TBL] [Abstract][Full Text] [Related]
15. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
[TBL] [Abstract][Full Text] [Related]
16. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
17. Angiostatin induces mitotic cell death of proliferating endothelial cells.
Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
[TBL] [Abstract][Full Text] [Related]
18. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
Luo X; Slater JM; Gridley DS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
[TBL] [Abstract][Full Text] [Related]
20. Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma.
Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
Radiat Oncol Investig; 1998; 6(2):71-80. PubMed ID: 9572683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
